Edwards, DexCom earn CE Mark for glucose monitoring system

Justine Varieur Cadet | | Health Imaging | Screening
Edwards Lifesciences, a developer of heart valves and hemodynamic monitoring systems, and DexCom have received a CE Mark for an automatic glucose monitoring system.

Irvine, Calif.-based Edwards and San Diego-based DexCom co-developed this new system, which is indicated for automatic, real-time monitoring and trending of blood glucose concentration in adult patients in the hospital environment.

The companies plan to begin deploying its first-generation system in a limited number of European sites before the end of the year.

Justine Varieur Cadet

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.